suicide substrate
Recently Published Documents


TOTAL DOCUMENTS

102
(FIVE YEARS 2)

H-INDEX

24
(FIVE YEARS 1)

2021 ◽  
Author(s):  
Yueqing Wang ◽  
Fengyi Xiang ◽  
Hao Deng ◽  
Shuang Leng ◽  
Dengze Zhao ◽  
...  

AbstractPancreatic cancer is one of the most aggressive and lethal malignancies with extremely poor prognosis, and KLK7 was considered as a potential therapeutic target. In this study, we analyzed the expression of KLK7 in TCGA and GTEx databases and found that KLK7 had a negative correlation to long-term survival rate (>1.5 years) of pancreatic cancer patients. Compound 42 is a coumarinic derivative, a suicide substrate inhibitor of KLK7, which has been proved to inhibit the proliferation of PANC-1 cells in vitro effectively in our previous study. In this study, we further investigated the inhibition ability of Compound 42 in tumor formation and development in CDX and PDX tumor models of pancreatic cancer subsequently. Besides, we studied the inhibitory mechanism of Compound 42 and the result showed that Compound 42 arrested the pancreatic cancer cell cycle in G0/G1 phase and induced ferroptosis through down-regulation of GPX4 protein level and accumulation of iron ion. Thus, these experiments demonstrate that Compound 42, suppressing pancreatic cancer in vivo, is expected to become a novel drug for pancreatic cancer treatment.


2019 ◽  
Vol 20 (17) ◽  
pp. 4245 ◽  
Author(s):  
Irina F. Sevrioukova

Human cytochrome P450 3A4 (CYP3A4) is the most important drug-metabolizing enzyme. Some drugs and natural compounds can act as suicide (mechanism-based) inactivators of CYP3A4, leading to unanticipated drug-drug interactions, toxicity and therapeutic failures. Despite significant clinical and toxicological implications, the mechanism-based inactivation remains incompletely understood. This study provides the first direct insights into the interaction of CYP3A4 with three suicide substrates: mibefradil, an antihypertensive drug quickly withdrawn from the market; a semi-synthetic antibiotic azamulin; and a natural furanocoumarin, 6′,7′-dihydroxybergamottin. Novel structural findings help better understand the suicide substrate binding and inhibitory mechanism, and can be used to improve the predictability of the binding ability, metabolic sites and inhibitory/inactivation potential of newly developed drugs and other chemicals relevant to public health.


2018 ◽  
Vol 22 (9) ◽  
pp. 1081-1085
Author(s):  
Chengjun Wu ◽  
Zhen Li ◽  
Chunchao Wang ◽  
Yanan Zhou ◽  
Tiemin Sun
Keyword(s):  

2017 ◽  
Vol 58 (12) ◽  
pp. 2310-2323 ◽  
Author(s):  
Medhanie E. Kidane ◽  
Boden H. Vanderloop ◽  
Wenxu Zhou ◽  
Crista D. Thomas ◽  
Emilio Ramos ◽  
...  

Biochemistry ◽  
2017 ◽  
Vol 56 (40) ◽  
pp. 5391-5404 ◽  
Author(s):  
Luca Mazzei ◽  
Michele Cianci ◽  
Umberto Contaldo ◽  
Francesco Musiani ◽  
Stefano Ciurli

2016 ◽  
Vol 138 (17) ◽  
pp. 5568-5575 ◽  
Author(s):  
Hajime Seki ◽  
Song Xue ◽  
Sabine Pellett ◽  
Peter Šilhár ◽  
Eric A. Johnson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document